XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 25.70

-3.6%

Jan 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Maxer who wrote (5132)	12/17/1997 4:33:00 PM
From: aknahow	Read Replies (3) of 17367

Max, spoke to Ellen Martin today. The glossary will be updated within days. Legal review being made. The FAQ will be updated prior to end of year. For the meningococcemia trials as of last Monday they were up to 115 patients. While 1998 could produce a Neuprex deal, Ellen, would not usethe same term as Murphy who said early 98. Other enhancements are planned for the site. The three patents which were recently granted are extensions of previous patents to protect improvements in procesing and proceedures.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next